165 related articles for article (PubMed ID: 26349496)
1. Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate.
Flores SE; Rial-Hermida MI; Ramirez JC; Pazos A; Concheiro A; Alvarez-Lorenzo C; Peralta RD
Mini Rev Med Chem; 2016; 16(6):498-508. PubMed ID: 26349496
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery.
Ustündağ Okur N; Yavaşoğlu A; Karasulu HY
Chem Pharm Bull (Tokyo); 2014; 62(2):135-43. PubMed ID: 24492583
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
Hu L; Yang J; Liu W; Li L
Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
[TBL] [Abstract][Full Text] [Related]
4. Parenteral microemulsions: an overview.
Date AA; Nagarsenker MS
Int J Pharm; 2008 May; 355(1-2):19-30. PubMed ID: 18295991
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
Karasulu HY; Karabulut B; Göker E; Güneri T; Gabor F
Drug Deliv; 2007 Apr; 14(4):225-33. PubMed ID: 17497355
[TBL] [Abstract][Full Text] [Related]
6. Microemulsions as a surrogate carrier for dermal drug delivery.
Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
[TBL] [Abstract][Full Text] [Related]
7. Application of microemulsions in dermal and transdermal drug delivery.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
[TBL] [Abstract][Full Text] [Related]
8. Microemulsions as potential drug delivery systems: a review.
Ansari MJ; Kohli K; Dixit N
PDA J Pharm Sci Technol; 2008; 62(1):66-79. PubMed ID: 18402369
[TBL] [Abstract][Full Text] [Related]
9. Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery.
Callender SP; Mathews JA; Kobernyk K; Wettig SD
Int J Pharm; 2017 Jun; 526(1-2):425-442. PubMed ID: 28495500
[TBL] [Abstract][Full Text] [Related]
10. Protein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agent.
Pepe D; McCall M; Zheng H; Lopes LB
J Pharm Sci; 2013 May; 102(5):1476-87. PubMed ID: 23436680
[TBL] [Abstract][Full Text] [Related]
11. Alkyl polyglucoside vs. ethoxylated surfactant-based microemulsions as vehicles for two poorly water-soluble drugs: physicochemical characterization and in vivo skin performance.
Pajić NZB; Todosijević MN; Vuleta GM; Cekić ND; Dobričić VD; Vučen SR; Čalija BR; Lukić MŽ; Ilić TM; Savić SD
Acta Pharm; 2017 Dec; 67(4):415-439. PubMed ID: 29337676
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible lecithin-based microemulsions with rhamnolipid and sophorolipid biosurfactants: formulation and potential applications.
Nguyen TT; Edelen A; Neighbors B; Sabatini DA
J Colloid Interface Sci; 2010 Aug; 348(2):498-504. PubMed ID: 20471022
[TBL] [Abstract][Full Text] [Related]
13. Development of water-in-oil microemulsions with the potential of prolonged release for oral delivery of L-glutathione.
Wen J; Du Y; Li D; Alany R
Pharm Dev Technol; 2013; 18(6):1424-9. PubMed ID: 23742726
[TBL] [Abstract][Full Text] [Related]
14. Influence of the composition of monoacyl phosphatidylcholine based microemulsions on the dermal delivery of flufenamic acid.
Hoppel M; Ettl H; Holper E; Valenta C
Int J Pharm; 2014 Nov; 475(1-2):156-62. PubMed ID: 25178824
[TBL] [Abstract][Full Text] [Related]
15. Potential of Non-aqueous Microemulsions to Improve the Delivery of Lipophilic Drugs to the Skin.
Carvalho VF; de Lemos DP; Vieira CS; Migotto A; Lopes LB
AAPS PharmSciTech; 2017 Jul; 18(5):1739-1749. PubMed ID: 27757922
[TBL] [Abstract][Full Text] [Related]
16. Potential of microemulsions in drug delivery and therapeutics: a patent review.
Bali V; Bhavna ; Ali M; Baboota S; Ali J
Recent Pat Drug Deliv Formul; 2008; 2(2):136-44. PubMed ID: 19075904
[TBL] [Abstract][Full Text] [Related]
17. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
[TBL] [Abstract][Full Text] [Related]
18. Microemulsions for oral administration and their therapeutic applications.
Gibaud S; Attivi D
Expert Opin Drug Deliv; 2012 Aug; 9(8):937-51. PubMed ID: 22663249
[TBL] [Abstract][Full Text] [Related]
19. Induction of Au-methotrexate conjugates by sugar molecules: production, assembly mechanism, and bioassay studies.
Wang WY; Zhao XF; Ju XH; Liu P; Li J; Tang YW; Li SP; Li XD; Song FG
Int J Pharm; 2018 Mar; 538(1-2):65-78. PubMed ID: 29341908
[TBL] [Abstract][Full Text] [Related]
20. Progress in the use of microemulsions for transdermal and dermal drug delivery.
Ita K
Pharm Dev Technol; 2017 Jun; 22(4):467-475. PubMed ID: 26931453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
